1 month FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates Zacks
FibroGen (FGEN) delivered earnings and revenue surprises of 55.26% and 36.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X